PREVALENCE OF MARKERS OF VIRAL HEPATITIS B AND D FROM HEALTHY POPULATION IN REPUBLIC TYVA
https://doi.org/10.22627/2072-8107-2014-13-2-13-16
Abstract
Aim: to estimate prevalence of markers, genetic diversity, risk factors of HBV and HDV infections in all age groups among healthy population in Republic Tyva. Serum samples obtained from healthy population in Republic Tyva (N = 1086) were tested (aged from birth to older 60 years). The markers of HBV and HDV infections were determined by enzyme immunoassay and PCR. HBsAg was detected in 7,7% (84/1086), anti-HBc — in 47,8% (519/1086) and HBeAg — in 0,3% (3/1086) cases. Prevalence of HBsAg in children under 9 years was 1,3%, no positive results of anti-HDV were determined among children aged up to 9 year. Prevalence of anti-HDV among HBsAg-positive individuals of healthy population was 32,1% (27/84). HBV DNA was detected in 2,9% (31/1086) cases; HDV RNA — in 32,1% (14/84) HBsAg-positive individuals. The obtained data showed high prevalence of HBV ang HDV infections among healthy population of Republic Tyva. Thus, it is necessary to extend screening program in this region to improve viral hepatitis surveillance and diagnostics. The sharp decline in the prevalence of these infections in children up to 9 years in the surveyed endemic region is an evidence of effective protection against HBV and HDV with vaccination against hepatitis B.
About the Authors
T. V. KozhanovaRussian Federation
Kozhanova Tatyana Viktorovna — PhD, senior researcher, FSBI «Chumakov IРVЕ», department of viral hepatitis. 142782, Moscow, settlement Moskovsky, community of the Institute of Poliomyelitis, 27 km Kievskoe shosse, tel. 8(495)540-90-12, e-mail: vkozhanov@bk.ru
L. Yu. Ilchenko
Russian Federation
V. V. Klushkina
Russian Federation
M. A. Lopatukhina
Russian Federation
E. P. Amon
Russian Federation
A. A. Saryglar
Russian Federation
O. V. Isaeva
Russian Federation
K. K. Kyuregyan
Russian Federation
M. I. Michailov
Russian Federation
References
1. Покровский В.И., Жебрун А.Б. Вирусные гепатиты в Российской Федерации: Аналитический обзор. 8 выпуск. — СПб.: ФБУН НИИЭМ имени Пастера, 2011. — 116 с.
2. К.К. Кюрегян, М.И. Михайлов. Молекулярно-биологические основы контроля вирусных гепатитов. — Москва: Издательство Икар, 2013. — 336 с.
3. Hamatake R.K. Hepatitis B and D protocols / Hamatake R.K., Lau J.Y.N. // Humana press Inc. — 2004. — V. 1. — P. 3—51.
4. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia / Ivaniushina V., Radjef N., Alexeeva M. et al. // J. Gen. Virol. — 2001. — V. 82. — P. 2709—2718.
5. Оценка влияния массовой вакцинации против гепатита В в Российской Федерации / Клушкина В.В., Кожанова Т.В., Бажажина П.Г. и др. // Журнал Микробиологии эпидемиологии и иммунобиологии. — 2012. — № 5. — С. 42—48.
6. Данные ФГУЗ «Центр гигиены и эпидемиологии Роспотребнадзор». http://www.fcgsen.ru/5/inform/index.htm (дата обращения 15.05.2014).
7. Virological and clinical characteristics of delta hepatitis in Central Europe / Heidrich B., Deterding K., Tillmann H. L. et al. // J. Viral. Hepat. — 2009. — V. 16. — P. 883—894.
8. Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis / Tulisov A., McMahon B., Koch A., Minuk G. et al. // ICCH13. Alaska Med. — 2007. — V. 49 (2 Suppl). — P. 193—203.
Review
For citations:
Kozhanova T.V., Ilchenko L.Yu., Klushkina V.V., Lopatukhina M.A., Amon E.P., Saryglar A.A., Isaeva O.V., Kyuregyan K.K., Michailov M.I. PREVALENCE OF MARKERS OF VIRAL HEPATITIS B AND D FROM HEALTHY POPULATION IN REPUBLIC TYVA. CHILDREN INFECTIONS. 2014;13(2):13-16. (In Russ.) https://doi.org/10.22627/2072-8107-2014-13-2-13-16